
PetMed Express, Inc. (PETS)
PetMed Express, Inc. (PETS) is a leading online pharmacy specializing in the sale of prescription and non-prescription pet medications, health products, and supplies. The company operates primarily through its website, PetMD, providing pet owners with convenient access to veterinary-approved products and advice. Established in 1996, PetMed Express focuses on delivering quality pet healthcare solutions with a focus on customer service and convenience.
Dividend History
Pay Date | Amount | Ex-Date | Record Date |
---|---|---|---|
August 18, 2023 | $0.30 | 2023-08-11 | 2023-08-14 |
June 12, 2023 | $0.30 | 2023-06-05 | 2023-06-06 |
February 27, 2023 | $0.30 | 2023-02-16 | 2023-02-20 |
November 30, 2022 | $0.30 | 2022-11-17 | 2022-11-18 |
August 19, 2022 | $0.30 | 2022-08-11 | 2022-08-12 |
Dividends Summary
- PetMed Express, Inc. has issued 58 dividend payments over the past 14 years
- The most recent dividend was paid 796 days ago, on August 18, 2023
- The highest dividend payed out to investors during this period was $1.00 per share
- The average dividend paid during this period was $0.22 per share.
Company News
PetMed Express is under investigation for potential financial misconduct, including delayed financial reporting, revenue recognition issues, and executive resignations after a whistleblower complaint.
Fiverr (FVRR) delivered earnings and revenue surprises of 0% and 1.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
This article highlights three dividend stocks whose weak Dividend Safety Grades were highlighted well before cuts that could have been avoided. Read more here.
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for Combination of Opioids and N-Acylethanolamines for pain treatment. Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) gained 53.1% to $0.3264 after the comp...
PetMed investors were suffering their worst day in 23 years, after the company reported disappointing quarterly results and said it would suspend its dividend.